Furosemide and Chylothorax - a phase IV clinical study of FDA data

Summary:

Chylothorax is reported as a side effect among people who take Furosemide (furosemide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Spironolactone, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Chylothorax when taking Furosemide. It is created by eHealthMe based on reports of 313,719 people who have side effects when taking Furosemide from the FDA, and is updated regularly.

What is Furosemide?

Furosemide has active ingredients of furosemide. It is often used in fluid retention. eHealthMe is studying from 316,095 Furosemide users. Check the latest studies of Furosemide.

What is Chylothorax?

Chylothorax (collection of lymph fluid around the lung) is found to be associated with 87 drugs and 134 conditions by eHealthMe. Check the latest studies of Chylothorax.

On Jul, 28, 2026

313,719 people reported to have side effects when taking Furosemide.
Among them, 23 people (0.01%) have Chylothorax.

Among these 23 people:

How long have people been on Furosemide when they have Chylothorax? *

What is the gender of people who have Chylothorax when taking Furosemide? *

female: 60.87 %
male: 39.13 %

What is the age of people who have Chylothorax when taking Furosemide? *

What are other drugs people take besides Furosemide? *

What are other side effects people have besides Chylothorax? *

Pleural Effusion (water on the lungs): 4 people, 17.39%
Rashes (redness): 3 people, 13.04%
Peripheral Swelling: 2 people, 8.70%
Catheter Site Erythema (redness of skin at catheter site): 2 people, 8.70%
Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer): 2 people, 8.70%
Mediastinitis (inflammation of the tissues in the mid-chest): 2 people, 8.70%
Drug Ineffective: 2 people, 8.70%
Wound Dehiscence (a surgical incision reopens either internally or externally): 2 people, 8.70%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 8.70%
Interstitial Lung Disease: 2 people, 8.70%

What are the existing conditions these people have? *

Pleural Effusion (water on the lungs): 4 people, 17.39%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 17.39%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 8.70%
Constipation: 2 people, 8.70%
Oedema Peripheral (superficial swelling): 2 people, 8.70%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 8.70%
Lymphoma (cancer that begins in immune system cells): 2 people, 8.70%
Insomnia (sleeplessness): 2 people, 8.70%
Injection Site Reaction: 2 people, 8.70%
Hypokalemia (low potassium): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Furosemide and have Chylothorax?

- Check whether Chylothorax is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Furosemide:

Furosemide (316,095 reports)

Chylothorax treatments and more:

Chylothorax (969 reports)

Browse all side effects of Furosemide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Chylothorax:

Chylothorax (87 drugs)

Browse all the conditions that are associated with Chylothorax:

Chylothorax (134 conditions)

Related publications that referenced our studies

Ochoa PS, Fisher T, "A 7‐Year Case of Furosemide‐Induced Immune Thrombocytopenia", Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013 Jul .
Ochoa PS, Fisher T, "A 7‐Year Case of Furosemide‐Induced Immune Thrombocytopenia", Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013 Jul .

How the study uses the data?

The study uses data from the FDA. It is based on furosemide (the active ingredients of Furosemide) and Furosemide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.